Caas Capital Management LP Fibrogen Inc Transaction History
Caas Capital Management LP
- $895 Million
- Q1 2025
A detailed history of Caas Capital Management LP transactions in Fibrogen Inc stock. As of the latest transaction made, Caas Capital Management LP holds 68,100 shares of FGEN stock, worth $20,430. This represents 0.02% of its overall portfolio holdings.
Number of Shares
68,100Holding current value
$20,430% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
65Shares Held
34.6MCall Options Held
461KPut Options Held
102K-
Armistice Capital, LLC New York, NY8.5MShares$2.55 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$1.76 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.17 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA3.74MShares$1.12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$722,8950.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $28.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...